Janusz J. Kulagowski

Statistics

Publications

Citations

3.3K

H-Index

Active since

1980

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Loughborough University

Janusz J. Kulagowski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and medicine.

ORCID

Publications per year

1980–2013

Publications

3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An Antagonist with High Affinity and Selectivity for the Human Dopamine D4 Receptor

Janusz J. Kulagowski, Howard B. Broughton, Neil R. Curtis et al. · Journal of Medicinal Chemistry · 1996 · 257 citations · Full text

Medicine, Pharmacology, Neurochemistry +4

Role of Dopamine D2-like Receptors in Cocaine Self-Administration: Studies with D2 Receptor Mutant Mice and Novel D2 Receptor Antagonists

S. Barak Caine, S. Stevens Negus, Nancy K. Mello et al. · Journal of Neuroscience · 2002 · 230 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

Martin R. Guscott, Linda J. Bristow, Karen L. Hadingham et al. · Neuropharmacology · 2005 · 227 citations

Medicine, Neuroscience, Pharmacology +14

Biological Profile of L-745,870, a Selective Antagonist with High Affinity for the Dopamine D4 Receptor

Smita S. Patel, Stephen B. Freedman, Kerry L. Chapman et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 166 citations

Medicine, Medicinal Chemistry, Pharmacology +17

3'-(Arylmethyl)- and 3'-(Aryloxy)-3-phenyl-4-hydroxyquinolin- 2(1H)-ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor

Janusz J. Kulagowski, R. BAKER, Neil R. Curtis · Journal of Medicinal Chemistry · 1994 · 139 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

1–5 of 55